p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function
Carlo Pincelli- Laboratory of Cutaneous Biology, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy
p75 neurotrophin receptor (p75NTR), also known as CD271, is the low-affinity receptor that, together with the tyrosine kinase receptor tropomyosin-receptor kinase (Trk), mediate neurotrophin (NT) functions. Beside their classic role in skin innervation, NT and their receptors constitute a complex cutaneous network associated with a number of autocrine and paracrine activities. In this context, the role of p75NTR is becoming more and more important. This review will focus on the intriguing functions of p75NTR in healthy and diseased skin. First, p75NTR counterbalances the proliferative and survival activities of its cognate receptor Trk by inducing keratinocyte apoptosis. In addition, p75NTR identifies an early transit-amplifying (TA) keratinocyte population and plays a critical role in keratinocyte stem cell transition to its progeny as well as in epidermal differentiation. p75NTR is absent in psoriatic TA cells, thus rendering these cells resistant to apoptosis. On the other hand, p75NTR infection restores NT-induced apoptosis in psoriatic keratinocytes. Taken together, these results provide evidence for a critical role of p75NTR in epidermal homeostasis, while its lack may account for the TA defect in psoriasis. While the issue of p75NTR as a marker of melanoma initiating cells is still to be solved, there is strong evidence that downregulation of this receptor is a precondition to melanoma invasion and metastasis in vitro and in vivo. All in all, this review points to p75NTR as a major actor in both physiologic and pathologic conditions at the skin level.
Introduction
The neurotrophin (NT) family of growth factors that includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), NT-3, and NT-4, plays a fundamental role in the development and maintenance of the nervous system (1). Each NT exerts its activities through two receptor classes: the high-affinity tropomyosin-receptor kinase (Trk) and the common p75 NT receptor (p75NTR, also known as CD271) (2).
p75NTR belongs to the tumor necrosis factor receptor family and interacts with a variety of ligands and co-receptors to mediate a range of functions, although this interplay is complex and still poorly understood (3). After ligand activation, p75NTR is proteolytically cleaved by γ-secretase to give intracellular domain (ICD) that is responsible for specific signaling (4). Heterodimerization of p75NTR with Trk increases the NT/Trk interaction affinity, thus augmenting growth and survival functions. In addition, pro-NTs bind to the sortilin-p75NTR complex and initiate cell death signaling (5). ICD in itself can operate independently of the other co-receptors and the functional activity of p75NTR depends on its subcellular localization, on the final location of the fragment (6, 7), and on which partners it is associated (8). p75NTR interacts with a variety of proteins (9) that in turn determine signaling through different pathways (10–12). This interplay allows p75NTR to play a flexible, but pivotal role in the regulation of multiple activities and ultimately the fate of the cell. The present review will focus on the current knowledge on p75NTR in healthy and diseased skin.
p75NTR Mediates NT-Sustained Skin Innervation
In the peripheral nervous system, the survival of sensory and sympathetic neurons largely depends on the production by innervated target of NGF and its cognate NTs (13). Overexpression of NGF in skin determines increase of sensory innervation (14). NGF production is proportional to the innervation density, and it is retrogradely transported to the cell body of the neuron where it regulates its maintenance (15). Also in skin, Trk receptors mediate NTs-enhanced cell survival, while p75NTR promotes cell death of sensory and sympathetic neurons (16). Mice carrying a mutation of gene encoding p75NTR display a marked decrease in sensory cutaneous innervation, associated with the development of ulcers in the distal extremities (17), indicating a critical role of p75NTR in the survival and functions of sensory neurons. In human skin, the intensity of p75NTR immunoreactivity in sensory nerves is stronger in areas where NGF is upregulated in target cells (18). Moreover, p75NTR is strongly increased in sensory fibers in conditions where keratinocytes express high levels of NGF (19).
p75NTR Outside the Nervous System
Beside the classical role of maintaining neuronal cells, NT and their receptors possess a range of functions outside the nervous system. Most non-neuronal cells express NT receptors and respond to NT stimuli, which implies for these neural substances, the role of actual growth factors and/or mediators in a number of physiologic (20) and pathologic conditions (21, 22). On the other hand, the function of p75NTR signaling alone or in combination with its co-receptors outside the nervous system has been largely overlooked and remains to be clarified.
NT Network in the Skin
Over the past 20 years, it has become clear that virtually every cutaneous cell synthesizes and releases NTs and expresses their receptors. Indeed, NGF is produced in basal keratinocytes and is involved in important autocrine functions (23, 24). Also, the other NTs are detected in keratinocytes where they exert similar activities (25).
In addition, the important observation that human melanocytes express all NTs and their receptors (26, 27) has been confirmed by the critical role these molecules and their receptors play in melanogenesis (28) and melanin production (27). This is further supported by the demonstration that NGF rescue melanocytes from apoptosis (29) and stimulates their migration and dendricity (30). Recently, Byun and co-workers have shown that NGF increases melanogenesis and plays a role in the pathogenesis of melasma (31). Interestingly, NTs and in particular p75NTR are expressed in neural crest (NC) cells, the melanocyte precursors (32).
While the role of NGF in wound repair has been known for a long time (33), NTs stimulate fibroblasts (34), one of the most important cell involved in this process. Myofibroblasts produce all NT and their receptors. Both p75NTR and Trks mediate fibroblast proliferation, differentiation, and migration. In addition, NGF or BDNF increase the tensile strength in a collagen gel (35), while tensile stimuli increase NGF in human fibroblasts (36). Recently, p75NTR has been shown to co-immunoprecipitate with the pro-inflammatory phosphodiesterases-4 in myofibroblasts (37), although the activities of this complex remain to be clarified.
Aloe and Levi-Montalcini originally observed that NGF enhances the number of mast cells in tissues (38). Since then, it is well accepted that there is a close contact between nerves and mast cells to form the “mast cell-nerve unit” that seems to play a key role in physiologic and pathophysiologic processes (39), with particular regard to itch and atopic dermatitis (40). Indeed, high levels of NT-3 are expressed in atopic dermatitis mast cells (41), and p75NTR is induced in lesional atopic mast cells (42).
These findings strongly indicate the presence of a complex NT network in the skin responsible for a number of autocrine and paracrine functions. In this context, a role for p75NTR has recently begun to emerge.
p75 and Hair Follicle
Neurotrophins and their receptors are involved in hair follicle morphogenesis in a complex manner. Consistent with the opposite roles of the two NT receptors, it would appear that NGF/TrkA promotes an anagen supporting role, whereas proNGF/p75 interaction is associated with a catagen-promoting effect (43). Moreover, NGF, but not BDNF, accelerates hair follicle development (44). On the other hand, BDNF inhibits hair shaft elongation and provokes catagen (45). NGF expression is also observed in keratinocytes of human hair follicles (46), with important implications for morphogenesis (47). Adly and co-workers reported that p75NTR protein displays a hair cycle-dependent fluctuation in human scalp (48), and p75NTR induces hair follicle involution via apoptosis (49).
p75NTR and Epidermal Homeostasis
Epidermal homeostasis is based on a fine balance between keratinocyte proliferation, differentiation, and apoptosis (50). Constant epidermal regeneration is achieved by stem cells that are slow-cycling and possess the capacity of self-renew (51). Keratinocyte stem cells (KSC) reside in the basal layer and generate transit-amplifying (TA) cells that undergo a limited number of cell divisions before committing to terminal differentiation (52), although this model has been recently questioned (53, 54).
Psoriasis is an immune-mediated dermatosis where alterations of epidermal homeostasis account for the main pathologic and clinical outcome. Indeed, psoriasis is characterized by keratinocyte hyperproliferation, abnormal differentiation, and increased resistance to apoptosis (55), resulting in excessive epidermal thickness, the key feature of psoriatic plaque. Thus, psoriasis is a perfect model of altered epidermal homeostasis that can be exploited for evaluating the expression and function of several molecules, including NTs.
Normal human keratinocytes synthesize and secrete all NTs and express their receptors. NGF is predominantly expressed in KSC (25), while TrkA is located only in basal keratinocytes with a uniform pattern (56). On the other hand, p75NTR is expressed in a subpopulation of basal keratinocytes with an irregular distribution (57). NGF levels are increased in psoriatic tissue (58) and keratinocytes (59). TrkA receptor is overexpressed throughout the epidermal layers in psoriatic skin (56), whereas p75NTR expression completely disappears in lesional psoriatic epidermis (57). These findings might be consistent with the general concept on the opposing effects Trks and p75NTR mediate in the nervous system (60). The following data confirm that this is actually the case also at the skin level.
Indeed, NGF or NT-3 stimulates keratinocyte growth (25, 61), and transfecting HaCat cells with TrkA enhance cell proliferation (62), indicating that NTs act as mitogens through their high-affinity receptor. Consistently, K252, a natural alkaloid that blocks Trk phosphorylation, thus inhibiting NT functions, prevents NGF-induced keratinocyte proliferation (23). In line with the increased expression of Trk and NGF (63) in psoriasis, topical treatment with K252 improves psoriasis in the immunodeficient mouse–human skin model (64). In psoriasis, keratinocyte apoptosis is spontaneously decreased (65), and psoriatic keratinocytes are resistant to apoptosis (66). Recently, PageRank analysis revealed a group of hub genes with anti-apoptotic functions in psoriasis (67).
Endogenous NGF acts as a survival factor for human keratinocytes through Trk receptor, as K252 induces cell death in these cells, by maintaining constant levels of the anti-apoptotic protein Bcl-2 (24). Furthermore, NGF protects keratinocytes from ultraviolet-B-induced apoptosis by preventing the cleavage of the enzyme poly (ADP-ribose) polymerase (61). Taken together, these data support the notion that NTs and Trk receptors mediate proliferative and survival activities in human keratinocytes. Abnormal mitotic and apoptotic processes mediated by NTs lead to the imbalanced epidermal homeostasis resulting in the excessive epidermal thickening observed in psoriasis (Figure 1).
Figure 1. p75NTR in epidermal homeostasis and psoriasis. In normal epidermis, there is a balance between p75NTR and tropomyosin-receptor kinase (Trk) receptors that controls proliferation, differentiation, and apoptosis and allows a perfect homeostasis. Upregulation of Trk and lack of p75NTR cause hyperproliferation, abnormal differentiation and reduced apoptosis that in turn are responsible for the altered epidermal homeostasis typical of psoriasis.
The absence of p75NTR as opposed to the increased Trk expression in lesional psoriatic epidermis (57) supports the hypothesis that an imbalance of the NT receptors could play an important role in the alterations of epidermal homeostasis observed in psoriasis. In normal human skin, binding of p75NTR with proper ligands mediates keratinocyte apoptosis. In fact, β amyloid, able to bind directly to p75NTR (68), activates caspase-3 only in keratinocytes expressing the low-affinity NT receptor. In addition, BDNF or NT-4, which signals only through p75NTR, induces apoptosis in human keratinocytes (57). In the nervous system, when both NT receptors are expressed, NT binds to Trk/p75 complex and mediate survival (69). On the other hand, in normal human keratinocytes, where both receptors are expressed, it appears that p75NTR can signal independently of Trk. This is in line with other studies in non-neuronal epithelial tissues. In fact, BDNF was recently shown to induce apoptosis in gingival epithelium via p75NTR (70), and p75NTR mediates apoptosis in prostate cancer cells (71), in the presence of Trk receptors. p75NTR independent signal mediating apoptosis in keratinocytes is further confirmed by the co-immunoprecipitation with its interacting protein NRAGE (57) that is known to disrupt p75NTR-Trk complex and to cause cell death through JNK-dependent pathway (72). In keeping with this concept, BDNF induces apoptosis in human keratinocytes through the phosphorylation of JNK (57). Taken together, these results indicate that p75NTR counteracts the survival and proliferative activities of Trk receptors, thus contributing to a normal epidermal homeostasis (Figure 1).
In human epidermis, differentiation begins when the transition from KSC to TA cells occurs, although the mechanisms underlying this process are still partially unknown.
p75NTR is predominantly expressed in the keratinocyte subpopulation enriched in TA cells (57). p75NTR-positive keratinocytes sorted from freshly isolated TA cells still retain KSC markers, such as survivin and keratin 15, while they express less markers of differentiation, as compared to p75NTR-negative cells. In addition, p75NTR-positive TA cells display a higher proliferative capacity and a better colony forming efficiency, as compared to p75NTR-negative cells. Finally, human reconstructed epidermis derived from p75NTR-positive TA cells express markers of early differentiation (73). This indicates that p75NTR identifies a population of early TA cells. A population of early TA has been already detected in the hair follicle (74) and in the interfollicular epidermis (75) and appears to be critical in the first steps of the differentiation process (76). p75NTR protein that exerts its activities at the boundary between KSC and TA could function as early trigger of keratinocyte differentiation. In fact, silencing p75NTR prevents calcium-induced keratinocyte differentiation and converts TA cells into a KSC phenotype. Moreover, overexpression of p75NTR in KSC results in a keratinocyte subpopulation with the features of TA cells (73). These results indicate that p75NTR could act as a “switch on-off” protein that critically regulates KSC-progeny transition and differentiation in human epidermis (Figure 1).
Excessive expansion of the TA cells compartment has been recently described in psoriatic skin (77), where a defect in TA subpopulation seems to account for the epidermal abnormalities observed in the disease (78). In addition, in silico studies have simulated psoriasis by altering the TA cells (79), and psoriatic TA cells are more advanced in their life cycle than their normal counterpart (80). p75NTR levels are strikingly reduced in psoriatic TA (57), and the lack of p75NTR seems to account for the reduced apoptosis of psoriatic keratinocytes. Indeed, BDNF fail to induce cell death in these cells, while overexpression of p75NTR restores their susceptibility to apoptosis (73). These findings suggest that alterations of the TA cell in psoriasis are at least in part due to a defect in p75NTR. Interestingly, skin equivalent models derived from p75NTR-negative TA cells display a psoriasiform phenotype (73) in line with the absence of the receptor protein in psoriasis (57). Because p75NTR plays a critical role in the early keratinocyte differentiation, it is tempting to speculate that the intrinsic defects in psoriatic epidermis occur in the early TA cells where the absence of p75NTR may account for the altered epidermal homeostasis of the disease. It has been shown that when keratinocytes exit the niche, they could undergo either differentiation or programmed cell death (81). Although p75NTR is clearly involved in both processes in human epidermis, the different triggers and pathways associated with the functions of the receptor remain to be elucidated.
p75NTR and Melanoma: More than Just a Marker
Melanoma cell lines synthesize and secrete all NTs and express NT receptors (82). p75NTR was first isolated from a melanoma cell line, and it has become a useful tool for immunohistochemical diagnosis of melanoma (83). High degree of p75NTR expression allows a better diagnosis of desmoplastic melanoma (84) and the distinction between spindle melanoma and other spindle cell tumors (85).
According to the “cancer stem cell” theory, a distinct subpopulation of melanoma cells (melanoma initiating cells, MIC) would account for the high tumorigenic properties, tumor heterogeneity, invasiveness, and drug resistance (86). p75NTR has received a special attention as a possible MIC marker because it is a marker of NC cells, the melanocyte precursors (87), and for the similarities between NC stem cells and melanoma cells (88). Yet, whether p75NTR identifies a group of highly tumorigenic MIC has not been clarified. It was first demonstrated that MIC express high levels of p75NTR and p75NTR-positive, but not p75NTR-negative transplanted melanoma cells are capable of inducing metastasis in vivo (89). On the other hand, Quintana and co-workers could not confirm these data, by showing that p75NTR -positive or p75NTR -negative melanoma cells have the same tumorigenic potential (90). Recently, Boyle and colleagues, using different patient-derived xenograft assays, have clearly shown that p75NTR-negative and p75NTR-positive melanoma cells from each of the patients had similar tumorigenic activity, concluding that p75NTR expression is unstable and not associated with increased tumorigenicity (91). This work also questions its role as a marker of melanoma aggressiveness (91). Consistently, p75NTR expression inversely correlates with hypoxia and melanoma invasiveness in vivo (92).
To definitely assess the role of p75NTR in melanoma, we have recently carried out an extensive study in vitro and in vivo (93). In skin equivalent models, p75NTR is highly expressed in early melanomas at the epidermal level and tends to disappear when melanoma starts to invade the dermis. In addition, p75NTR is completely absent in skin reconstructs derived from metastatic cell lines. p75NTR expression is highest in spheroids derived from primary melanoma cells, it decreases in cells derived from metastatic melanomas to disappear in highly invasive spheroids. p75NTR-negative cells show greater proliferation and invasiveness in vitro and are associated with a higher number of metastases in zebrafish, as compared with p75NTR-positive cells. Moreover, silencing p75NTR induces a more aggressive phenotype in spheroids and in the animal model. By contrast, p75NTR overexpression reduces invasiveness in vitro and strikingly reduces the number of metastases in zebrafish. This seems to indicate that p75NTR switch off is critical for melanoma progression and metastasis (Figure 2).
Figure 2. p75 neurotrophin receptor (p75NTR) and melanoma. p75NTR is associated with less aggressive melanoma, while it tends to decrease and disappear during melanoma invasion and metastasis.
Conclusion
There is compelling evidence that, in the context of the skin NT network, p75NTR is a major actor in both physiological and pathological conditions. In healthy skin, p75NTR-triggered differentiation and de-differentiation during KSC to progeny transition awaits confirmation in other epidermal stem cell compartments as well as in the mouse model. In addition, more studies are needed to understand the mechanisms underlying the absence of p75NTR protein in psoriasis, and whether the lack of the receptor, that is critical for epidermal homeostasis, is associated with a psoriatic phenotype also in vivo.
While the downregulation of p75NTR as a precondition for melanoma progression and metastasis is unquestionable, the molecular mechanisms associated with this function are not fully clarified. The low levels of β1 integrin and the decreased of cell-to-cell adhesion in the absence of p75NTR could predispose melanoma to increased invasiveness (93). Furthermore, melanoma is characterized by an alteration of the apoptotic machinery. The lack of p75NTR that exerts pro-apoptotic functions in melanoma (94), could favor tumor cell survival and metastasis.
Author Contributions
The author confirms being the sole contributor of this work and approved it for publication.
Conflict of Interest Statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The author would like to thank Roberta Lotti and Annalisa Saltari for critical revising and editing of the manuscript.
References
1. Bothwell M. NGF, BDNF, NT3, and NT4. Handb Exp Pharmacol (2014) 220:3–15. doi: 10.1007/978-3-642-45106-5_1
2. Marchetti L, Luin S, Bonsignore F, de Nadai T, Beltram F, Cattaneo A. Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches. Int J Mol Sci (2015) 16(1):1949–79. doi:10.3390/ijms16011949
3. Ibáñez CF, Simi A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci (2012) 35(7):431–40. doi:10.1016/j.tins.2012.03.007
4. Vilar M, Mira H. Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles. Front Neurosci (2016) 10:26. doi:10.3389/fnins.2016.00026
5. Meeker R, Williams K. Dynamic nature of the p75 neurotrophin receptor in response to injury and disease. J Neuroimmune Pharmacol (2014) 9(5):615–28. doi:10.1007/s11481-014-9566-9
6. Bronfman FC, Fainzilber M. Multi-tasking by the p75 neurotrophin receptor: sortilin things out? EMBO Rep (2004) 5(9):867–71. doi:10.1038/sj.embor.7400219
7. Skeldal S, Matusica D, Nykjaer A, Coulson EJ. Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling? Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). Bioessays (2011) 33(8):614–25. doi:10.1002/bies.201100036
8. Vilar M, Charalampopoulos I, Kenchappa RS, Reversi A, Klos-Applequist JM, Karaca E, et al. Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J Cell Sci (2009) 122:3351–7. doi:10.1242/jcs.055061
9. Barker PA. p75NTR is positively promiscuous: novel partners and new insights. Neuron (2004) 42:529–33. doi:10.1016/j.neuron.2004.04.001
10. Troy CM, Friedman JE, Friedman WJ. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J Biol Chem (2002) 277:34295–302. doi:10.1074/jbc.M205167200
11. Becker EB, Howell J, Kodama Y, Barker PA, Bonni A. Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci (2004) 24(40):8762–70. doi:10.1523/JNEUROSCI.2953-04.2004
12. Linggi MS, Burke TL, Williams BB, Harrington A, Kraemer R, Hempstead BL, et al. Neurotrophin receptor interacting factor (NRIF) is an essential mediator of apoptotic signaling by the p76 neurotrophic receptor. J Biol Chem (2005) 280(14):13801–8. doi:10.1074/jbc.M410435200
13. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron (2003) 39:69–84. doi:10.1016/S0896-6273(03)00397-0
14. Davis BM, Fundin BT, Albers KM, Goodness TP, Cronk KM, Rice FL. Overexpression of nerve growth factor in skin causes preferential increases among innervation to specific sensory targets. J Comp Neurol (1997) 387(4):489–506. doi:10.1002/(SICI)1096-9861(19971103)387:4<489::AID-CNE2>3.0.CO;2-Z
15. Wyatt SL, Spori B, Vizard TN, Davies AM. Selective regulation of nerve growth factor expression in developing cutaneous tissue by early sensory innervation. Neural Dev (2011) 6:1–8. doi:10.1186/1749-8104-6-18
16. Bothwell M. Neurotrophin function in skin. J Investig Dermatol Symp Proc (1997) 2(1):27–30. doi:10.1038/jidsymp.1997.7
17. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell (1992) 69(5):737–49. doi:10.1016/0092-8674(92)90286-L
18. Dou YC, Hagströmer L, Emtestam L, Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res (2006) 298(1):31–7. doi:10.1007/s00403-006-0657-1
19. Raychaudhuri SP, Raychaudhuri SK. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res (2004) 146:433–7. doi:10.1016/S0079-6123(03)46027-5
20. Aloe L, Rocco ML, Bianchi P, Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med (2012) 10(239):1–15. doi:10.1186/1479-5876-10-239
21. Scuri M, Samsell L, Piedimonte G. The role of neurotrophins in inflammation and allergy. Inflamm Allergy Drug Targets (2010) 9(3):173–80. doi:10.2174/187152810792231913
22. Seidel MF, Lane NE. Control of arthritis pain with anti-nerve-growth factor: risk and benefit. Curr Rheumatol Rep (2012) 14(6):583–8. doi:10.1007/s11926-012-0289-8
23. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol (1994) 103(1):13–8. doi:10.1111/1523-1747.ep12388914
24. Pincelli C, Haake AR, Benassi L, Grassilli E, Magnoni C, Ottani D, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol (1997) 109(6):757–64. doi:10.1111/1523-1747.ep12340768
25. Marconi A, Terracina M, Fila C, Franchi J, Bonté F, Romagnoli G, et al. Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol (2003) 121(6):1515–21. doi:10.1111/j.1523-1747.2003.12624.x
26. Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest (1994) 94(4):1550–62. doi:10.1172/JCI117496
27. Marconi A, Panza MC, Bonnet-Duquennoy M, Lazou K, Kurfurst R, Truzzi F, et al. Expression and function of neurotrophins and their receptors in human melanocytes. Int J Cosmet Sci (2006) 28(4):255–61. doi:10.1111/j.1467-2494.2006.00321.x
28. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. Biofactors (2009) 35(2):193–9. doi:10.1002/biof.29
29. Zhai S, Yaar M, Doyle SM, Gilchrest BA. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res (1996) 224(2):335–43. doi:10.1006/excr.1996.0143
30. Yaar M, Grossman K, Eller M, Gilchrest BA. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol (1991) 115:821–8. doi:10.1083/jcb.115.3.821
31. Byun JW, Park IS, Choi GS, Shin J. Role of fibroblast-derived factors in the pathogenesis of melasma. Clin Exp Dermatol (2016) 41(6):601–9. doi:10.1111/ced.12874
32. Pelaez D, Huang CY, Cheung HS. Isolation of pluripotent neural crest-derived stem cells from adult human tissues by connexin-43 enrichment. Stem Cells Dev (2013) 22(21):2906–14. doi:10.1089/scd.2013.0090
33. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A, et al. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med (1998) 187(3):297–306. doi:10.1084/jem.187.3.297
34. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A (2001) 98(11):6162–7. doi:10.1073/pnas.101130898
35. Palazzo E, Marconi A, Truzzi F, Dallaglio K, Petrachi T, Humbert P, et al. Role of neurotrophins on dermal fibroblast survival and differentiation. J Cell Physiol (2012) 227(3):1017–25. doi:10.1002/jcp.22811
36. Kim M, Shin DW, Shin H, Noh M, Shin JH. Tensile stimuli increase nerve growth factor in human dermal fibroblasts independent of tension-induced TGFβ production. Exp Dermatol (2013) 22(1):72–4. doi:10.1111/exd.12064
37. Schafer PH, Truzzi F, Parton A, Wu L, Kosek J, Zhang LH, et al. Phosphodiesterase 4 in inflammatory diseases: effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex. Cell Signal (2016) 28(7):753–63. doi:10.1016/j.cellsig.2016.01.007
38. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res (1977) 133(2):358–66. doi:10.1016/0006-8993(77)90772-7
39. Forsythe P, Bienenstock J. The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses. Chem Immunol Allergy (2012) 98:196–221. doi:10.1159/000336523
40. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci (2009) 53(1):48–54. doi:10.1016/j.jdermsci.2008.08.011
41. Quarcoo D, Fischer TC, Peckenschneider N, Groneberg DA, Welker P. High abundances of neurotrophin 3 in atopic dermatitis mast cell. J Occup Med Toxicol (2009) 4(8):1–7. doi:10.1186/1745-6673-4-8
42. Fischer TC, Lauenstein HD, Serowka F, Pilzner C, Groneberg DA, Welker P. Pan-neurotrophin receptor p75NTR expression is strongly induced in lesional atopic mast cells. Clin Exp Allergy (2008) 38(7):1168–73. doi:10.1111/j.1365-2222.2008.02994.x
43. Peters EM, Hendrix S, Gölz G, Klapp BF, Arck PC, Paus R. Nerve growth factor and its precursor differentially regulate hair cycle progression in mice. J Histochem Cytochem (2006) 54(3):275–88. doi:10.1369/jhc.4A6585.2005
44. Botchkareva NV, Botchkarev VA, Albers KM, Metz M, Paus R. Distinct roles for nerve growth factor and brain-derived neurotrophic factor in controlling the rate of hair follicle morphogenesis. J Invest Dermatol (2000) 114(2):314–20. doi:10.1046/j.1523-1747.2000.00864.x
45. Peters EM, Hansen MG, Overall RW, Nakamura M, Pertile P, Klapp BF, et al. Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor beta2 expression. J Invest Dermatol (2005) 124(4):675–85. doi:10.1111/j.0022-202X.2005.23648.x
46. Adly MA, Assaf HA, Nada EA, Soliman M, Hussein M. Expression of nerve growth factor and its high-affinity receptor, tyrosine kinase A proteins, in the human scalp skin. J Cutan Pathol (2006) 33(8):559–68. doi:10.1111/j.1600-0560.2006.00443.x
47. Botchkarev VA, Botchkareva NV, Peters EM, Paus R. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Prog Brain Res (2004) 146:493–513. doi:10.1016/S0079-6123(03)46031-7
48. Adly MA, Assaf HA, Hussein MR. Expression pattern of p75 neurotrophin receptor protein in human scalp skin and hair follicles: hair cycle-dependent expression. J Am Acad Dermatol (2009) 60(1):99–109. doi:10.1016/j.jaad.2008.09.060
49. Peters EM, Stieglitz MG, Liezman C, Overall RW, Nakamura M, Hagen E, et al. p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (catagen). Am J Pathol (2006) 168(1):221–34. doi:10.2353/ajpath.2006.050163
50. Livshits G, Kobielak A, Fuchs E. Governing epidermal homeostasis by coupling cell-cell adhesion to integrin and growth factor signaling, proliferation, and apoptosis. Proc Natl Acad Sci U S A (2012) 109:4886–91. doi:10.1073/pnas.1202120109
51. Pincelli C, Marconi A. Keratinocyte stem cells: friends and foes. J Cell Physiol (2010) 225(2):310–5. doi:10.1002/jcp.22275
52. Kaur P. Interfollicular epidermal stem cells: identification, challenges, potential. J Invest Dermatol (2006) 126(7):1450–8. doi:10.1038/sj.jid.5700184
53. Clayton E, Doupé DP, Klein AM, Winton DJ, Simons BD, Jones PH. A single type of progenitor cell maintains normal epidermis. Nature (2007) 446:185–9. doi:10.1038/nature05574
54. Sada A, Jacob F, Leung E, Wang S, White BS, Shalloway D, et al. Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin. Nat Cell Biol (2016) 18(6):619–31. doi:10.1038/ncb3359
55. Simonart T, Heenen M, Lejeune O. Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal. Cell Prolif (2010) 43(3):321–5. doi:10.1111/j.1365-2184.2010.00672.x
56. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol (2000) 10(2):85–90.
57. Truzzi F, Marconi A, Atzei P, Panza MC, Lotti R, Dallaglio K, et al. p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. Cell Death Differ (2011) 18(6):948–58. doi:10.1038/cdd.2010.162
58. Fantini F, Magnoni C, Bracci-Laudiero L, Pincelli C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol (1995) 105(6):854–5. doi:10.1111/1523-1747.ep12326689
59. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol (1998) 78(2):84–6. doi:10.1080/000155598433368
60. Ceni C, Unsain N, Zeinieh MP, Barker PA. Neurotrophins in the regulation of cellular survival and death. Handb Exp Pharmacol (2014) 220:193–221. doi:10.1007/978-3-642-45106-5_8
61. Marconi A, Vaschieri C, Zanoli S, Giannetti A, Pincelli C. Nerve growth factor protects human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol (1999) 113(6):920–7. doi:10.1046/j.1523-1747.1999.00773.x
62. Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci (2000) 22(2):71–9. doi:10.1016/S0923-1811(99)00065-1
63. Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol (2008) 172(4):961–71. doi:10.2353/ajpath.2008.070710
64. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol (2004) 122(3):812–9. doi:10.1111/j.0022-202X.2003.12602.x
65. Laporte M, Galand P, Fokan D, de Graef C, Heenen M. Apoptosis in established and healing psoriasis. Dermatology (2000) 200(4):314–6. doi:10.1159/000018394
66. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol (1997) 151(5):1321–9.
67. Zeng X, Zhao J, Wu X, Shi H, Liu W, Cui B, et al. PageRank analysis reveals topologically expressed genes correspond to psoriasis and their functions are associated with apoptosis resistance. Mol Med Rep (2016) 13(5):3969–76. doi:10.3892/mmr.2016.4999
68. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J Clin Invest (1997) 100:2333–40. doi:10.1172/JCI119772
69. Chao MV, Bothwell M. Neurotrophins: to cleave or not to cleave. Neuron (2002) 33:9–12. doi:10.1016/S0896-6273(01)00573-6
70. Kashiwai K, Kajiya M, Matsuda S, Ouhara K, Takeda K, Takata T, et al. Distinction between cell proliferation and apoptosis signals regulated by brain-derived neurotrophic factor in human periodontal ligament cells and gingival epithelial cells. J Cell Biochem (2016) 117(7):1543–55. doi:10.1002/jcb.25446
71. Khwaja FS, Quann EJ, Pattabiraman N, Wynne S, Djakiew D. Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells. Mol Cancer Ther (2008) 7(11):3539–45. doi:10.1158/1535-7163.MCT-08-0512
72. Salehi AH, Xanthoudakis S, Barker PA. NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem (2002) 277:48043–50. doi:10.1074/jbc.M205324200
73. Truzzi F, Saltari A, Palazzo E, Lotti R, Petrachi T, Dallaglio K, et al. CD271 mediates stem cells to early progeny transition in human epidermis. J Invest Dermatol (2015) 135(3):786–95. doi:10.1038/jid.2014.454
74. Gutiérrez-Rivera A, Pavón-Rodríguez A, Jiménez-Acosta F, Poblet E, Braun KM, Cormenzana P, et al. Functional characterization of highly adherent CD34+ keratinocytes isolated from human skin. Exp Dermatol (2010) 19(7):685–8. doi:10.1111/j.1600-0625.2010.01075.x
75. Li A, Pouliot N, Redvers R, Kaur P. Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. J Clin Invest (2004) 113(3):390–400. doi:10.1172/JCI19140
76. Schlüter H, Kaur P. In vivo transplantation assay at limiting dilution to identify the intrinsic tissue reconstitutive capacity of keratinocyte stem cells and their progeny. Methods Mol Biol (2013) 989:165–82. doi:10.1007/978-1-62703-330-5_14
77. Jia HY, Shi Y, Luo LF, Jiang G, Zhou Q, Xu SZ, et al. Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesions. Int J Mol Med (2016) 37(2):359–68. doi:10.3892/ijmm.2015.2445
78. Castelijns FA, Gerritsen MJ, van Erp PE, van de Kerkhof PC. Cell-kinetic evidence for increased recruitment of cycling epidermal cells in psoriasis: the ratio of histone and Ki-67 antigen expression is constant. Dermatology (2000) 201(2):105–10. doi:10.1159/000018471
79. Grabe N, Neuber K. Simulating psoriasis by altering transit amplifying cells. Bioinformatics (2007) 23(11):1309–12. doi:10.1093/bioinformatics/btm042
80. Franssen ME, Zeeuwen PL, Vierwinden G, van de Kerkhof PC, Schalkwijk J, van Erp PE. Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis. J Invest Dermatol (2005) 124(2):373–83. doi:10.1111/j.0022-202X.2004.23612.x
81. Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ (2000) 7(12):1218–24. doi:10.1038/sj.cdd.4400785
82. Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol (2008) 128(8):2031–40. doi:10.1038/jid.2008.21
83. Ordóñez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol (2014) 45(2):191–205. doi:10.1016/j.humpath.2013.02.007
84. Miller DD, Emley A, Yang S, Richards JE, Lee JE, Deng A, et al. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Mod Pathol (2012) 25(4):505–15. doi:10.1038/modpathol.2011.196
85. Sigal AC, Keenan M, Lazova R. p75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin. Am J Dermatopathol (2012) 34:145–50. doi:10.1097/DAD.0b013e318225b596
86. Alamodi AA, Eshaq AM, Hassan SY, Al Hmada Y, El Jamal SM, Fothan AM, et al. Cancer stem cell as therapeutic target for melanoma treatment. Histol Histopathol (2016) 31(12):1291–301. doi:10.14670/HH-11-791
87. Nishimura EK, Jordan SA, Oshima H, Yoshida H, Osawa M, Moriyama M, et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature (2002) 416(6883):854–60. doi:10.1038/416854a
88. Shakhova O. Neural crest stem cells in melanoma development. Curr Opin Oncol (2014) 26(2):215–21. doi:10.1097/CCO.0000000000000046
89. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 466(7302):133–7. doi:10.1038/nature09161
90. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 18(5):510–23. doi:10.1016/j.ccr.2010.10.012
91. Boyle SE, Fedele CG, Corbin V, Wybacz E, Szeto P, Lewin J, et al. CD271 expression on patient melanoma cells is unstable and unlinked to tumorigenicity. Cancer Res (2016) 76(13):3965–77. doi:10.1158/0008-5472.CAN-15-2377
92. Marconi A, Borroni RG, Truzzi F, Longo C, Pistoni F, Pellacani G, et al. Hypoxia-inducible factor-1α and CD271 inversely correlate with melanoma invasiveness. Exp Dermatol (2015) 24(5):396–8. doi:10.1111/exd.12679
93. Saltari A, Truzzi F, Quadri M, Lotti R, Palazzo E, Grisendi G, et al. CD271 down-regulation promotes melanoma progression and invasion in three-dimensional models and in zebrafish. J Invest Dermatol (2016) 136(10):2049–58. doi:10.1016/j.jid.2016.05.116
Keywords: p75 neurotrophin receptor, CD271, neurotrophins, skin, epidermis, homeostasis, melanoma, psoriasis
Citation: Pincelli C (2017) p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function. Front. Med. 4:22. doi: 10.3389/fmed.2017.00022
Received: 21 December 2016; Accepted: 16 February 2017;
Published: 07 March 2017
Edited by:
Alexander A. Navarini, University of Zurich, SwitzerlandCopyright: © 2017 Pincelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carlo Pincelli, carlo.pincelli@unimore.it